1. Home
  2. LENZ vs JYNT Comparison

LENZ vs JYNT Comparison

Compare LENZ & JYNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LENZ Therapeutics Inc.

LENZ

LENZ Therapeutics Inc.

HOLD

Current Price

$3.22

Market Cap

106.8M

Sector

Health Care

ML Signal

HOLD

Logo The Joint Corp.

JYNT

The Joint Corp.

HOLD

Current Price

$7.36

Market Cap

100.7M

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
LENZ
JYNT
Founded
2019
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Multi-Sector Companies
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
106.8M
100.7M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
LENZ
JYNT
Price
$3.22
$7.36
Analyst Decision
Buy
Hold
Analyst Count
7
4
Target Price
★ $23.86
$10.00
AVG Volume (30 Days)
★ 744.4K
67.0K
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 133.93
EPS
N/A
★ 0.14
Revenue
$19,088,000.00
★ $117,696,356.00
Revenue This Year
N/A
$10.93
Revenue Next Year
$152.18
$2.78
P/E Ratio
★ N/A
$50.86
Revenue Growth
N/A
★ 15.49
52 Week Low
$3.12
$6.79
52 Week High
$32.92
$10.67

Technical Indicators

Market Signals
Indicator
LENZ
JYNT
Relative Strength Index (RSI) 32.50 46.75
Support Level N/A $6.79
Resistance Level $6.11 $9.43
Average True Range (ATR) 0.21 0.23
MACD 0.00 0.06
Stochastic Oscillator 13.89 95.08

Price Performance

Historical Comparison
LENZ
JYNT

About LENZ LENZ Therapeutics Inc.

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.

Share on Social Networks: